首页> 外国专利> COMPOSITION FOR USE IN TREATING OR PREVENTING VIRAL OR BACTERIAL INFECTIONS IN SUBJECT UNDERGOING ANTI-TUMOR CHEMOTHERAPY, TREATING LEUKEMIA OR TREATING AIDS CONTAINING L.REUTERI LER03 AND/OR L.SALIVARIUS LS06

COMPOSITION FOR USE IN TREATING OR PREVENTING VIRAL OR BACTERIAL INFECTIONS IN SUBJECT UNDERGOING ANTI-TUMOR CHEMOTHERAPY, TREATING LEUKEMIA OR TREATING AIDS CONTAINING L.REUTERI LER03 AND/OR L.SALIVARIUS LS06

机译：用于治疗或预防正在接受抗肿瘤化学疗法，治疗白血病或治疗包含L.REUTERI LER03和/或L.SALIVARIUS LS06的艾滋病的病毒或细菌感染的组合物

页面导航

摘要
著录项
相似文献

摘要

FIELD: medicine; pharmaceuticals.;SUBSTANCE: invention relates to pharmaceutical industry, namely to use of composition as antiviral and/or antibacterial agent in individuals undergoing anti-tumour chemotherapeutic treatment, treating acquired immunodeficiency syndrome and treating leukaemia. Use of the composition containing a mixture consisting of: a strain of bacteria belonging to type Lactobacillus reuteri, identified as Lactobacillus reuteri LRE03, with depositary number DSM 23879 and/or bacterial strain belonging to type Lactobacillus salivarius, identified as Lactobacillus salivarius LS06, as an antiviral and/or antibacterial agent in individuals undergoing anti-tumour chemotherapeutic treatment, treatment of acquired immunodeficiency syndrome and treatment of leukaemia.;EFFECT: composition described above stimulates production of anti-inflammatory cytokines (Th1) of interferon INF-gamma, wherein said cytokines exhibit pronounced antiviral and/or antibacterial activity, stimulate production of dendritic cells, wherein said dendritic cells also exhibit manifested antiviral and/or antibacterial activity.;10 cl, 2 tbl, 6 dwg

机译：领域：医学;药物本发明涉及制药工业，即涉及该组合物在接受抗肿瘤化学治疗，治疗获得性免疫缺陷综合症和治疗白血病的个体中作为抗病毒和/或抗菌剂的用途。包含由以下组成的混合物的组合物的使用：保藏号为DSM 23879的属于罗伊氏乳杆菌类型的细菌菌株，被标识为罗伊氏乳杆菌 LRE03和/或细菌菌株属于唾液乳杆菌的类型，被鉴定为唾液乳杆菌 LS06效果：上述组合物刺激干扰素INF-γ的抗炎细胞因子（Th1）的产生，其中所述细胞因子表现出显着的抗病毒和/或抗菌活性，刺激树突细胞的产生，其中所述树突细胞也表现出明显的抗病毒和/或抗菌活性。; 10 cl，2 tbl，6 dwg 展开▼

著录项

公开/公告号RU2713414C2

专利类型

公开/公告日2020-02-05

原文格式PDF

申请/专利权人 MOGNA GIOVANNI;
展开▼

申请/专利号RU20160143921

发明设计人 MOGNA GIOVANNI (IT);
展开▼

申请日2015-04-30

分类号A61K35/74;A61P31/04;A61P31/12;

国家 RU

入库时间 2022-08-21 11:02:39

相似文献

专利

外文文献

中文文献

1. 用于预防或治疗经历抗肿瘤化疗、白血病治疗或AIDS治疗的受试者的病毒或细菌感染的含罗伊氏乳杆菌LER03和/或唾液乳杆菌LS06的组合物 [P] . 中国专利： CN106573022A . 2017-04-19

2. 抗病毒化合物、其药学上可接受的盐或光学异构体、用于制备它们的方法以及包含它们作为有效成分的用于预防或治疗病毒性疾病的药物组合物 [P] . 中国专利： CN105121433B . 2018.01.23

3. COMPOSITION FOR USE IN TREATING OR PREVENTING VIRAL OR BACTERIAL INFECTIONS IN SUBJECT UNDERGOING ANTI-TUMOR CHEMOTHERAPY, TREATING LEUKEMIA OR TREATING AIDS CONTAINING L.REUTERI LER03 AND/OR L.SALIVARIUS LS06 [P] . 俄罗斯专利： RU2016143921A3 . 2018-12-18

机译：用于治疗或预防正在接受抗肿瘤化学疗法，治疗白血病或治疗包含L.REUTERI LER03和/或L.SALIVARIUS LS06的艾滋病的病毒或细菌感染的组合物

4. L. LER03 / L. LS06 - A COMPOSITION FOR USE IN TREATING OR PREVENTING VIRAL OR BACTERIAL INFECTIONS IN A SUBJECT UNDERGOING ANTI-TUMOR CHEMOTHERAPY LEUKEMIA TREATMENT OR AIDS THERAPY COMPRISING L. REUTERI LER03 AND/OR L. SALIVARIUS LS06 [P] . 韩国专利： KR20160144501A . 2016-12-16

机译： L. LER03 / L. LS06-用于治疗或预防正在接受抗肿瘤化学疗法治疗或爱滋病治疗的病毒性或细菌性感染的组合物

5. Composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising L. reuteri LER03 and/or L. salivarius LS06 [P] . US11077153B2 . 2021-08-03

机译：用于治疗或预防抗肿瘤化疗，白血病治疗或艾滋病治疗的受试者中病毒或细菌感染的组合物。 Reuteri ler03和/或 l。唾液 ls06

1. COMPARISON OF CLINICAL OBSERVATIONS BETWEEN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ALL-TRANS RETINOIC ACID AND CHEMOTHERAPY [J] . 张芬琴, 吴立德, 李秀松, 上海交通大学学报：医学英文版 . 1992,第002期

2. Chlamydia trachomatis infections in Nicaragua: preliminary results from a competitive voucher scheme to prevent and treat sexually transmitted infections and HIV/AIDS among sex workers. [J] . Gorter AC, Segura ZE, Savelkoul PH, Drugs of today: Medicamentos de actualidad . 2006,第Suppla1期

3. How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation [J] . Waghmare Alpana, Englund Janet A., Boeckh Michael Blood: The Journal of the American Society of Hematology . 2016,第22期

4. Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant [J] . Sili U., Leen A.M., Vera J.F., Cytotherapy . 2012,第1期

5. Inhalable Dry Powder Microparticles for Delivery of Bacteriophages to Treat Cystic Fibrosis Associated Bacterial Lung Infections [C] . Rachit Agarwal, Christopher Johnson, Andres J Garcia Society for Biomaterials annual meeting and exposition . 2015

6. Selection of Lactic Acid Bacteria and Their Metabolites for Preventing and Treating Infections. [D] . Wang, Yvonne. 2012

7. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia [O] . Elvira C van Dalen, Arno Mank, Edith Leclercq, -1

8. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart [O] . V Garcia-Martinez, C Lopez Sanchez, W Hamed, 2016

1. CLINICAL INVESTIGATION OF TRADITIONAL CHINESE MEDICINE AND PHARMACY IN TREATING RESPIRATORY TRACT INFECTIONS IN AIDS [J] . 李国勤 ,岳玉和 ,吕维柏 . 中医杂志：英文版 . 1996,第1期

2. Abatement of Helminth Eggs and Bacterial and Viral Indicators in Soil after Land Application of Treated Sludges [J] . Claudia Campos ,Milena Beltrán ,Marcela Duarte . 水资源与保护（英文） . 2013,第12期

3. Spinal Epidural Myeloid Sarcoma with Paraplegia in Acute Myeloid Leukemia Treated with Radiation and Chemotherapy: A Case Report [J] . Chiaki Sato ,Naohisa Miyakoshi ,Michio Hongo . 矫形学期刊（英文） . 2019,第6期

4. 239 CASES OF HIGH FEVER IN VIRAL UPPERRESPIRATORY INFECTION (URI) TREATED WITHXIANG SHI QING JIE (XSQJ) BAG TEA [J] . 刘征利 ,李洪海 ,彭征屏 . 中医杂志：英文版 . 1996,第2期

5. 品管圈活动对接受核苷(酸)类似物治疗的院外慢性乙型肝炎患者抗病毒治疗依从性影响 [C] . 张雪雪 ,王晓娟 ,王林林 . 河南省传染病专科护理理论与技术创新学术会议 . 2018

6. PLWHA接受与维持艾滋病抗病毒治疗的现状及其影响因素研究 [A] . 文湖钧 . 2018